Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

NUSAP1 Enhances Drug Resistance By Binding to RAD51 through DNA Damage Repair Pathway in Chronic Lymphocytic Leukemia

Yang Han, MM, Ya Zhang, MD, Xinting Hu, MM, Xiang Sun, BS, Xin Wang, MDPhD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-141815

Published: 2020

Journal Articles

CTP Synthase 2: A Novel Prognostic Biomarker and Potential Therapeutic Target in Chronic Lymphocytic Leukemia

Ya Zhang, MD, Xinting Hu, MM, Yang Han, MM, Xiangxiang Zhou, MD, Na Chen, MD, Peipei Li, PhD, Kang Lu, PhD, Xin Wang, MDPhD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-139836

Published: 2020

Journal Articles

Comprehensive Profiling of the Epitranscriptomic N6-Methyladenosine RNA Methylation in Chronic Lymphocytic Leukemia

Ya Zhang, MD, Xinting Hu, MM, Hongzhi Xu, MD, Ying Li, MD, Lingyan Zhang, MD, Lili Feng, MD, Xiangxiang Zhou, MD, Xiaosheng Fang, MD PhD, Yujie Jiang, MD, Mei Ding, MD, Jianhong Wang, Xin Wang, MDPhD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-141758

Published: 2020

Journal Articles

Prognostic Role of C-Reactive Protein, C-Reactive Protein Kinetics and C-Reactive Protein/ Albumin Ratio in Newly Diagnosed B-Cell Chronic Lymphoproliferative Diseases

Huimin Zhang, BS, Ya Zhang, MD, Xiangxiang Zhou, MD, Xiang Sun, BS, Yang Han, MM, Xinting Hu, MM, Xiaoya Yun, BS, Xin Wang, MDPhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-138704

Published: 2020

Journal Articles

Targeting Inhibition of N 6 -Methyladenosine Demethylase Fto Displays Potent Anti-Tumor Activities in Chronic Lymphocytic Leukemia

Ya Zhang, MD, Xinting Hu, MM, Yang Han, MM, Xiangxiang Zhou, MD, Huimin Zhang, BS, Xiaoya Yun, BS, Xin Wang, MDPhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-139526

Published: 2020

Journal Articles

NUSAP1 Promotes Cell Proliferation Via the DNA Damage Response Pathway in Diffuse Large B-Cell Lymphoma

Yang Han, MM, Ya Zhang, MD, Juan Yang, PhD, Jiarui Liu, Tan Sang, Shunfeng Hu, MM, Xinting Hu, MM, Xin Wang, MDPhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-141859

Published: 2020

Journal Articles

CD20-Modified Exosomes Delivered E260 Inhibits Progression of Diffuse Large B-Cell Lymphoma By Restoring Hippo Activity

Jiarui Liu, Xiangxiang Zhou, MD, Ya Zhang, MD, Shunfeng Hu, MM, Yang Han, MM, Juan Yang, PhD, Yi Zhao, MM, Shuai Ren, MM, Yiqing Cai, Xin Wang, MDPhD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-138723

Published: 2020

Journal Articles

N6-Methyladenosine RNA Methylation Regulators Contribute to Malignant Progression and Survival Prediction in Chronic Lymphocytic Leukemia

Ya Zhang, MD, Xiaosheng Fang, PhD, Na Chen, MD, Xiao Lv, PhD, Xueling Ge, PhD, Kang Lu, MD PhD, Xiangxiang Zhou, MD, Juan Yang, MM, Yang Han, MM, Shunfeng Hu, Xin Wang, MD PhD

Blood (2019) 134 (Supplement_1): 1738.

https://doi.org/10.1182/blood-2019-126469

Published: 2019

Journal Articles

Blockade of Yes-Associated Protein As a Novel Therapeutic Approach in Diffuse Large B-Cell Lymphoma

Xiangxiang Zhou, MD, Juan Yang, MM, Ya Zhang, MD, Ying Li, MD, Xiaosheng Fang, MD, Na Chen, MD, Xin Wang, MD PhD

Blood (2019) 134 (Supplement_1): 808.

https://doi.org/10.1182/blood-2019-129695

Published: 2019

Journal Articles

NCAPD3 Regulates Tumor Growth and Predicts Prognosis in Diffuse Large B-Cell Lymphoma

Juan Yang, MM, Ying Li, MD, Ya Zhang, MD, Xiangxiang Zhou, MD, Yi Zhao, MM, Yang Han, MM, Jiarui Liu, MM, Xin Wang, MD PhD

Blood (2019) 134 (Supplement_1): 5045.

https://doi.org/10.1182/blood-2019-123910

Published: 2019

Journal Articles

Targeting Sirt6 with OSS_128167 Displays Anti-Tumor Activities in Diffuse Large B-Cell Lymphoma through Down-Regulation of PI3K Signaling

Juan Yang, MM, Xiangxiang Zhou, MD, Ying Li, MD, Ya Zhang, MD, Xiaosheng Fang, MD, Na Chen, MD, Xin Wang, MD PhD

Blood (2019) 134 (Supplement_1): 5065.

https://doi.org/10.1182/blood-2019-127926

Published: 2019

Journal Articles

Differentially Expressed Trfs in Relapsed & Refractory Diffuse Large B Cell Lymphoma and the Bioinformatic Analysis for Their Potential Clinical Use

Qingyuan Qu, Yujie Jiang, MD, Ying Li, MD, Yiqing Cai, Ya Zhang, MD, Xin Wang, MD PhD

Blood (2018) 132 (Supplement 1): 5121.

https://doi.org/10.1182/blood-2018-99-118134

Published: 2018

Journal Articles

Suppression of CUL4B Induces G1 Cell Cycle Arrest through the Modulation of AKT Signaling Pathway

Ying Li, MD, Ya Zhang, MD, Xiangxiang Zhou, MD, Xin Wang, MDPhD

Blood (2018) 132 (Supplement 1): 5133.

https://doi.org/10.1182/blood-2018-99-118442

Published: 2018

Journal Articles

Discovery of a Novel Five Immune-Associated Fingerprints for Classification and Survival Prediction in Chronic Lymphocytic Leukemia

Ya Zhang, MD, Ying Li, MD, Xiangxiang Zhou, MD, Xin Wang, MDPhD

Blood (2018) 132 (Supplement 1): 4403.

https://doi.org/10.1182/blood-2018-99-116252

Published: 2018

Journal Articles

SIRT6 As a Potential Therapeutic Target in Diffuse Large B-Cell Lymphoma

Juan Yang, PhD, Ying Li, MD, Ya Zhang, MD, Xiangxiang Zhou, MD, Xin Wang, MD PhD

Blood (2018) 132 (Supplement 1): 2862.

https://doi.org/10.1182/blood-2018-99-115823

Published: 2018

Journal Articles

Targeting Maternal Embryonic Leucine Zipper Kinase with OTSSP167 Displays Anti-Tumor Activities in Chronic Lymphocytic Leukemia through Down-Regulation of FoxM1

Ya Zhang, MD, Xiangxiang Zhou, MD, Ying Li, MD, Yangyang Xu, MD, Xin Wang, MD PhD

Blood (2017) 130 (Supplement 1): 801.

https://doi.org/10.1182/blood.V130.Suppl_1.801.801

Published: 2017

Journal Articles

Cullin4B Induces Autophagy Participating the Tumorigenesis of Diffuse Large B-Cell Lymphoma

Ying Li, MD, Xiangxiang Zhou, MD, Ya Zhang, MD, Yangyang Xu, MD, Juan Yang, MD, Xin Wang, MD PhD

Blood (2017) 130 (Supplement 1): 2541.

https://doi.org/10.1182/blood.V130.Suppl_1.2541.2541

Published: 2017

Journal Articles

Prognostic Importance of DOCK1 Transcript Levels, and Biologic Insights from DOCK1 -Associated Gene and Microrna Expression Signatures in De Novo acute Myeloid Leukemia

Ya Zhang, MD, Ying Li, MD, Lingyan Zhang, MD, Xiaosheng Fang, MD, Changqing Zhen, MD, Xin Wang, MD PhD

Blood (2017) 130 (Supplement 1): 3952.

https://doi.org/10.1182/blood.V130.Suppl_1.3952.3952

Published: 2017

Journal Articles

Expression of YAP and Inhibitory Effect By IGF-1R Suppressor in Diffuse Large B-Cell Lymphoma

Xiangxiang Zhou, MD, Ying Li, MD, Ya Zhang, MD, Yangyang Xu, BD, Dai Yuan, MD, Xin Wang, MD PhD

Blood (2016) 128 (22): 892.

https://doi.org/10.1182/blood.V128.22.892.892

Published: 2016

Journal Articles

Klotho/IGF-1R Regulates Tumor Growth and Predicts Prognosis in Diffuse Large B-Cell Lymphoma

Xiangxiang Zhou, MD, Ying Li, MD, Xinyu Li, MD, Lingyun Geng, MD, Ya Zhang, MD, Yujie Jiang, PhD, Xin Wang, MD PhD

Blood (2016) 128 (22): 2924.

https://doi.org/10.1182/blood.V128.22.2924.2924

Published: 2016

NARROW

NUSAP1 Enhances Drug Resistance By Binding to RAD51 through DNA Damage Repair Pathway in Chronic Lymphocytic Leukemia

CTP Synthase 2: A Novel Prognostic Biomarker and Potential Therapeutic Target in Chronic Lymphocytic Leukemia

Comprehensive Profiling of the Epitranscriptomic N6-Methyladenosine RNA Methylation in Chronic Lymphocytic Leukemia

Prognostic Role of C-Reactive Protein, C-Reactive Protein Kinetics and C-Reactive Protein/ Albumin Ratio in Newly Diagnosed B-Cell Chronic Lymphoproliferative Diseases

Targeting Inhibition of N 6 -Methyladenosine Demethylase Fto Displays Potent Anti-Tumor Activities in Chronic Lymphocytic Leukemia

NUSAP1 Promotes Cell Proliferation Via the DNA Damage Response Pathway in Diffuse Large B-Cell Lymphoma

CD20-Modified Exosomes Delivered E260 Inhibits Progression of Diffuse Large B-Cell Lymphoma By Restoring Hippo Activity

N6-Methyladenosine RNA Methylation Regulators Contribute to Malignant Progression and Survival Prediction in Chronic Lymphocytic Leukemia

Blockade of Yes-Associated Protein As a Novel Therapeutic Approach in Diffuse Large B-Cell Lymphoma

NCAPD3 Regulates Tumor Growth and Predicts Prognosis in Diffuse Large B-Cell Lymphoma

Targeting Sirt6 with OSS_128167 Displays Anti-Tumor Activities in Diffuse Large B-Cell Lymphoma through Down-Regulation of PI3K Signaling

Differentially Expressed Trfs in Relapsed & Refractory Diffuse Large B Cell Lymphoma and the Bioinformatic Analysis for Their Potential Clinical Use

Suppression of CUL4B Induces G1 Cell Cycle Arrest through the Modulation of AKT Signaling Pathway

Discovery of a Novel Five Immune-Associated Fingerprints for Classification and Survival Prediction in Chronic Lymphocytic Leukemia

SIRT6 As a Potential Therapeutic Target in Diffuse Large B-Cell Lymphoma

Targeting Maternal Embryonic Leucine Zipper Kinase with OTSSP167 Displays Anti-Tumor Activities in Chronic Lymphocytic Leukemia through Down-Regulation of FoxM1

Cullin4B Induces Autophagy Participating the Tumorigenesis of Diffuse Large B-Cell Lymphoma

Prognostic Importance of DOCK1 Transcript Levels, and Biologic Insights from DOCK1 -Associated Gene and Microrna Expression Signatures in De Novo acute Myeloid Leukemia

Expression of YAP and Inhibitory Effect By IGF-1R Suppressor in Diffuse Large B-Cell Lymphoma

Klotho/IGF-1R Regulates Tumor Growth and Predicts Prognosis in Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only